<?xml version="1.0" encoding="UTF-8"?>
<p id="par0155">For the time being, we will need to rely on serology for diagnostic confirmation. During the past three years, with the international focus on emerging flaviviruses following the chikungunya virus and theZika virus global epidemics, there have been intensified efforts to reduce cost, increase throughput, and improve specificity. These include the analysis of IgA (
 <xref rid="bib0020" ref-type="bibr">Amaro et al., 2019</xref>, 
 <xref rid="bib0790" ref-type="bibr">Warnecke et al., 2019</xref>, 
 <xref rid="bib0195" ref-type="bibr">Colonetti et al., 2018</xref>, 
 <xref rid="bib0540" ref-type="bibr">Nascimento et al., 2018</xref>, 
 <xref rid="bib0625" ref-type="bibr">Rockstroh et al., 2017</xref>, 
 <xref rid="bib0875" ref-type="bibr">Zhang et al., 2017</xref>, 
 <xref rid="bib0360" ref-type="bibr">Huang et al., 2017</xref>, 
 <xref rid="bib0055" ref-type="bibr">Balmaseda et al., 2008</xref>, 
 <xref rid="bib0050" ref-type="bibr">Balmaseda et al., 2003</xref>, 
 <xref rid="bib0855" ref-type="bibr">Yap et al., 2011</xref>) and IgG subclasses (
 <xref rid="bib0540" ref-type="bibr">Nascimento et al., 2018</xref>), antibody avidity (
 <xref rid="bib0020" ref-type="bibr">Amaro et al., 2019</xref>, 
 <xref rid="bib0205" ref-type="bibr">de Vasconcelos et al., 2018</xref>, 
 <xref rid="bib0630" ref-type="bibr">Ronnberg et al., 2017</xref>, 
 <xref rid="bib0770" ref-type="bibr">Tsai et al., 2018</xref>, 
 <xref rid="bib0695" ref-type="bibr">Shen et al., 2017</xref>), incorporation of blocking agents, IgG depletion (
 <xref rid="bib0125" ref-type="bibr">Calvert et al., 2018</xref>) and production of specific monoclonal antibodies for identification of specific viral epitopes (
 <xref rid="bib0885" ref-type="bibr">Zhu et al., 2018</xref>, 
 <xref rid="bib0460" ref-type="bibr">Lebani et al., 2017</xref>, 
 <xref rid="bib0580" ref-type="bibr">Piyasena et al., 2017</xref>, 
 <xref rid="bib0400" ref-type="bibr">Kim et al., 2018b</xref>, 
 <xref rid="bib0265" ref-type="bibr">Frietze et al., 2017</xref>). This recent work highlights the inherent challenges of serological techniques for JE identification. As Lindsey et al. describe, antigenic cross-reactivity between related viruses can make it virtually impossible to distinguish the cause of the infection (
 <xref rid="bib0485" ref-type="bibr">Lindsey et al., 2018</xref>). For example, cross-reactive IgM class antibodies may not be stimulated during a related secondary flavivirus infection. On the other hand, IgA may be produced during a secondary flavivirus infection, and a laboratory-defined ‘seroconversion’ might be detected following a secondary flavivirus infection by a related flavivirus.
</p>
